Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1488 studies found for:    neuroscience
Show Display Options
Rank Status Study
21 Unknown  Brain Computer Interface (BCI) Based Robotic Rehabilitation for Stroke
Condition: Stroke
Intervention: Other: Rehabilitation technique
22 Unknown  Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
Conditions: Recurrent Glioblastoma Multiforme;   Recurrent Gliosarcoma
Intervention: Drug: temozolomide and bevacizumab
23 Unknown  European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus
Condition: Normal Pressure Hydrocephalus
Intervention: Procedure: Ventriculo-peritoneal Shunt
24 Recruiting Peripheral Physiological Measures as Determinants of Pain Risk
Conditions: Polyneuropathies;   Peripheral Nerve Injuries;   Peripheral Nervous System Diseases;   Chemotherapy Effects;   Neuralgia
Intervention: Other: Multiple Excitability Measures of peripheral nerves
25 Completed Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] AZD2423 in Volunteers
Condition: Neuroscience
Intervention: Drug: AZD2423
26 Completed The Study of Effectiveness Repetitive Transcranial Magnetic Stimulation in Bipolar Depression
Condition: Bipolar Disorder
Intervention: Device: Transcranial Magnetic stimulation
27 Recruiting Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
Conditions: Alzheimer Disease;   CVA (Cerebrovascular Accident)
Intervention: Drug: Rivastigmine
28 Terminated A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches
Condition: Migraine Headache
Intervention: Drug: ramelteon
29 Completed Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia
Condition: Schizophrenia
Interventions: Behavioral: Targeted cognitive training (TCT);   Behavioral: Computer games
30 Completed Neuromodulation to Facilitate the Effect of Ketamine
Conditions: Depression;   Chronic Pain;   Substance Abuse
Intervention: Other: co-administration of TMS and infused ketamine
31 Completed
Has Results
A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients
Condition: Drooling
Interventions: Biological: Botulinum Toxin Type B (Myobloc);   Biological: Matched placebo to Myobloc
32 Active, not recruiting Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis
Condition: Schizophrenia
Interventions: Behavioral: Neuroadaptive cognitive training;   Behavioral: Computer games
33 Completed Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)
Condition: Obsessive Compulsive Disorder
Intervention: Drug: ondansetron
34 Recruiting Cognitive Remediation for Alcohol Use Disorder and Posttraumatic Stress Disorder
Conditions: Alcohol Use Disorder;   PTSD;   Cognitive Dysfunction
Interventions: Behavioral: Cognitive Training;   Behavioral: Cognitive training placebo control
35 Completed A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: rasagiline mesylate;   Drug: Rasagiline mesylate plus Mirapex;   Drug: Rasagiline mesylate with Levodopa;   Drug: Rasagiline mesylate with Requip
36 Completed A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone
Condition: Multiple Sclerosis
Intervention: Procedure: Shared Solutions® plus MS Center v. Shared Solutions®
37 Completed A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy
Condition: Multiple Sclerosis
38 Completed A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.
Condition: Multiple Sclerosis
Intervention: Procedure: Alcohol Wipes vs. No Alcohol Wipes
39 Recruiting HT-3951 vs. Placebo in Stroke Rehabilitation
Condition: Ischemic Stroke
Interventions: Drug: HT-3951;   Drug: Placebo
40 Completed The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function
Condition: Human Volunteers
Interventions: Drug: EVT 101;   Drug: placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.